The goal of this clinical trial is to compare the combination albendazole and praziquantel versus albendazole alone in patients affected by neurocysticercosis.
Living in the study area for a continuous period of 3 years
Adult aged 18 years and above
Are willing and able to consent to this study
Meet the definitions of active symptomatic NCC
Women pregnant or breastfeeding
Symptomatic NCC with cysts in extra-parenchymal location (sub-arachnoid and/or ventricles)
Have uncontrolled hypertension and/or diabetes
Have chronic consuming illness such as cancer or mental handicap to not allow them to follow the study instructions
R-Evolution Worldwide S.r.l. Impresa Sociale
Lead sponsor
Muhimbili University of Health and Allied Sciences
Collaborator
National Institute for Medical Research, Tanzania
Collaborator
Sokoine University of Agriculture
Collaborator
University of Zambia
Collaborator
University Ghent
Collaborator